Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 42.84 USD 1.47% Market Closed
Market Cap: 3.4B USD

Relative Value

The Relative Value of one VCYT stock under the Base Case scenario is hidden USD. Compared to the current market price of 42.84 USD, Veracyte Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VCYT Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
38
vs Industry
57
Median 3Y
5.6
Median 5Y
6
Industry
7.9
Forward
6.5
vs History
6
vs Industry
1
Median 3Y
-30.3
Median 5Y
-36.8
Industry
23.7
Forward
81.8
vs History
53
vs Industry
5
Median 3Y
42
Median 5Y
35
Industry
22
vs History
39
vs Industry
5
Median 3Y
47.1
Median 5Y
26.6
Industry
23.8
vs History
25
vs Industry
39
Median 3Y
1.8
Median 5Y
1.9
Industry
3.3
vs History
38
vs Industry
51
Median 3Y
5
Median 5Y
5.4
Industry
8.3
Forward
5.8
vs History
38
vs Industry
47
Median 3Y
7.3
Median 5Y
8
Industry
10.1
vs History
30
vs Industry
2
Median 3Y
42.2
Median 5Y
-38.2
Industry
6.4
Forward
22.6
vs History
20
vs Industry
1
Median 3Y
-27.3
Median 5Y
-40.5
Industry
7
Forward
90.2
vs History
53
vs Industry
5
Median 3Y
37.1
Median 5Y
30.5
Industry
8.3
vs History
39
vs Industry
4
Median 3Y
42.2
Median 5Y
22.9
Industry
6.5
vs History
25
vs Industry
44
Median 3Y
1.8
Median 5Y
2
Industry
5.7

Multiples Across Competitors

VCYT Competitors Multiples
Veracyte Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Veracyte Inc
NASDAQ:VCYT
3.4B USD 6.8 111.7 42.9 62.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 798 004.3 -160 636.9 -195 064.4 -192 838.5
US
Abbvie Inc
NYSE:ABBV
394.7B USD 6.6 168.1 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.9B USD 4.8 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
149.5B USD 5.1 18.4 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.4 -531.9 -579.2 -563.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD 5.5 17.1 16.2 18.4
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.7 13.2 16.5
NL
argenx SE
XBRU:ARGX
45.9B EUR 15 35.2 60.9 62.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 202.7 158 191.6
P/E Multiple
Earnings Growth PEG
US
Veracyte Inc
NASDAQ:VCYT
Average P/E: 180.9
111.7
59%
1.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 636.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.4
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
9%
1.9
AU
CSL Ltd
ASX:CSL
19.7
11%
1.8
NL
argenx SE
XBRU:ARGX
35.2
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 202.7
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Veracyte Inc
NASDAQ:VCYT
Average EV/EBITDA: 40.1
42.9
58%
0.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 064.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
13.2
8%
1.7
NL
argenx SE
XBRU:ARGX
60.9
839%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Veracyte Inc
NASDAQ:VCYT
Average EV/EBIT: 47.7
62.9
77%
0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 838.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
62.5
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.6
N/A N/A